CDX-1127

CDX-1127 · Celldex Therapeutics

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CDX-1127, covering 2018-05-17 to 2024-02-06. Get the full timeline:

Most recent: Clinical Trial Update: Vaccination With 6MHP, With or Without Systemic CDX-1127, in Patients With Stage II-IV Melanoma [Phase 1, Phase 2]

See pricing